Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient
Condition(s):Argininosuccinate Synthetase DeficientLast Updated:April 9, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Argininosuccinate Synthetase DeficientLast Updated:April 9, 2014Completed
Condition(s):CitrullinemiaLast Updated:March 20, 2015Completed
Condition(s):Urea Cycle DisordersLast Updated:February 14, 2023Recruiting
Condition(s):Metastatic Melanoma; Skin Cancer; NeoplasmLast Updated:October 25, 2022Completed
Condition(s):Glioblastoma Multiforme (GBM)Last Updated:June 12, 2023Recruiting
Condition(s):Advanced Gastrointestinal (GI) Malignancies; Hepatocellular Carcinoma; Gastric Cancer; Colorectal CancerLast Updated:April 25, 2022Terminated
Condition(s):Hepatocellular CarcinomaLast Updated:March 4, 2016Completed
Condition(s):Advanced Pancreatic CancerLast Updated:October 1, 2020Completed
Condition(s):Pleural Mesothelioma Malignant Advanced; Peritoneal Mesothelioma Malignant Advanced; Non-squamous Non-small Cell Lung Carcinoma; Uveal Melanoma; Hepatocellular Carcinoma; Glioma; Sarcomatoid CarcinomaLast Updated:September 25, 2020Terminated
Condition(s):Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid TumorsLast Updated:February 25, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.